223 related articles for article (PubMed ID: 12409000)
1. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway.
Amarante LH; Duarte ID
Eur J Pharmacol; 2002 Nov; 454(1):19-23. PubMed ID: 12409000
[TBL] [Abstract][Full Text] [Related]
2. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine.
Amarante LH; Alves DP; Duarte ID
Eur J Pharmacol; 2004 Jun; 494(2-3):155-60. PubMed ID: 15212969
[TBL] [Abstract][Full Text] [Related]
3. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat.
Romero TR; Duarte ID
Eur J Pharmacol; 2009 Jun; 613(1-3):64-7. PubMed ID: 19389395
[TBL] [Abstract][Full Text] [Related]
4. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
5. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.
Jain NK; Patil CS; Singh A; Kulkarni SK
Brain Res; 2001 Aug; 909(1-2):170-8. PubMed ID: 11478933
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
Patil CS; Jain NK; Singh VP; Kulkarni SK
Indian J Exp Biol; 2004 Apr; 42(4):361-7. PubMed ID: 15088685
[TBL] [Abstract][Full Text] [Related]
8. NO/cGMP production is important for the endogenous peripheral control of hyperalgesia during inflammation.
Alves DP; da Motta PG; Romero TR; Klein A; Duarte ID
Nitric Oxide; 2013 Jan; 28():8-13. PubMed ID: 22995857
[TBL] [Abstract][Full Text] [Related]
9. Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
Tasatargil A; Sadan G
Anesth Analg; 2004 Jan; 98(1):185-192. PubMed ID: 14693616
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the L-arginine/Nitric Oxide/Cyclic GMP/KATP Channel Pathway and PPARγ Receptors in the Peripheral Antinociceptive Effect of Carbamazepine.
Ghorbanzadeh B; Kheirandish V; Mansouri MT
Drug Res (Stuttg); 2019 Dec; 69(12):650-657. PubMed ID: 31272117
[TBL] [Abstract][Full Text] [Related]
11. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Duarte ID; Ferreira SH
Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
[TBL] [Abstract][Full Text] [Related]
12. delta-opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom.
Picolo G; Giorgi R; Cury Y
Eur J Pharmacol; 2000 Mar; 391(1-2):55-62. PubMed ID: 10720635
[TBL] [Abstract][Full Text] [Related]
13. Peripheral antinociception of a chalcone, flavokawin B and possible involvement of the nitric oxide/cyclic guanosine monophosphate/potassium channels pathway.
Kamaldin MN; Akhtar MN; Mohamad AS; Lajis N; Perimal EK; Akira A; Ming-Tatt L; Israf DA; Sulaiman MR
Molecules; 2013 Apr; 18(4):4209-20. PubMed ID: 23612473
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
[TBL] [Abstract][Full Text] [Related]
15. The L-arginine/nitric oxide/cyclic-GMP pathway apparently mediates the peripheral antihyperalgesic action of fentanyl in rats.
Maegawa FA; Tonussi CR
Braz J Med Biol Res; 2003 Dec; 36(12):1701-7. PubMed ID: 14666255
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia.
Nakamura A; Fujita M; Shiomi H
Br J Pharmacol; 1996 Feb; 117(3):407-412. PubMed ID: 8821527
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
[TBL] [Abstract][Full Text] [Related]
18. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
19. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
[TBL] [Abstract][Full Text] [Related]
20. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
